| NDC Code | 70934-396-90 |
|---|
| Package Description | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-396-90) |
|---|
| Product NDC | 70934-396 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Verapamil Hydrochloride |
|---|
| Non-Proprietary Name | Verapamil Hydrochloride |
|---|
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20190625 |
|---|
| End Marketing Date | 20230831 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA090700 |
|---|
| Manufacturer | Denton Pharma, Inc. DBA Northwind Pharmaceuticals |
|---|
| Substance Name | VERAPAMIL HYDROCHLORIDE |
|---|
| Strength | 120 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
|---|